Table 4.

New/worsening EIMs in UC patients [GEMINI 1]^a

EIM, n [%]	GEMINI 1 [UC]
	VDZ n = 620	VDZ/PLA n = 126	PLA n = 149
Arthritis/arthralgia	58 [9]	16 [13]	11 [7]
Aphthous stomatitis	2 [<1]	0 [0]	0 [0]
Erythema nodosum	5 [<1]	1 [<1]	0 [0]
Iritis/uveitis	4 [<1]	0 [0]	0 [0]
Pyoderma gangrenosum	1 [<1]	0 [0]	0 [0]

EIM, extraintestinal manifestation; PLA, placebo; UC, ulcerative colitis; VDZ, vedolizumab.

^aIncidence expressed as the percentage of all patients in each treatment group.